Pleasanton, CA, United States of America

Nipun Davar

This inventor holds 11 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Alza Corporation, Molecular Templates, Inc.. Active years: 2001-2025.

USPTO Granted Patents = 11 (Patent Applications = 18)

% Patents Active = 72.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 81(Granted Patents)

Location History:

Fremont, CA (US) (2001 - 2016)
Pleasanton, CA (US) (2018 - 2024)

Company Filing History:

5 out of 846

Otsuka Pharmaceutical Company, Limited

Molecular Templates, Inc.

Taiho Pharmaceutical Company Limited

patents

Years Active: 2001-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12239653 - Combination decitabine and cedazuridine solid oral dosage forms (2025-03-04),

2. 12195496 - 2'-deoxy-2′,2′-difluorotetrahydrouridines with high purity and methods of making the same (2025-01-14),

3. 12187757 - 2'-deoxy-2′,2′-difluorotetrahydrouridines with high purity and methods of making the same (2025-01-07),

4. 11963971 - Combination decitabine and cedazuridine solid oral dosage forms (2024-04-23),

5. 10858386 - Drug compound and purification methods thereof (2020-12-08),

6. 10654876 - TH-302 solid forms and methods related thereto (2020-05-19),

7. 10519190 - Drug compound and purification methods thereof (2019-12-31),

8. 10131683 - TH-302 solid forms and methods related thereto (2018-11-20),

9. 9393192 - Methods and dosage forms for controlled delivery of paliperidone and risperidone (2016-07-19),

10. 7335193 - Osmotically-driven fluid dispenser (2008-02-26),

11. 6224907 - Anti-asthma therapy (2001-05-01),

Title: The Innovative Contributions of Nipun Davar

Introduction

Nipun Davar, based in Pleasanton, California, is a distinguished inventor known for his significant contributions to the pharmaceutical field. With a total of eight patents to his name, Davar has been pivotal in advancing drug formulation and synthesis techniques. His innovative thinking addresses critical challenges in medication delivery and efficacy.

Latest Patents

Among his latest patents, Davar has developed a remarkable combination of decitabine and cedazuridine in solid oral dosage forms. This invention aims to provide plasma levels of decitabine through daily oral administration, achieving results equivalent to those achieved with a standard intravenous dose. Additionally, Davar has created methods for synthesizing 2'-deoxy-2′,2′-difluorotetrahydrouridine with enhanced purity. These methods focus on effective crystallization and isolation procedures that minimize impurities, ensuring a high-quality final product.

Career Highlights

Throughout his career, Nipun Davar has worked with reputable organizations, including Otsuka Pharmaceutical Company and Molecular Templates, Inc. His experience in these companies has driven his innovative research, leading to substantial advancements in drug development and formulation.

Collaborations

Davar has collaborated with several notable professionals during his career. Among his coworkers are Rajashree Joshi-Hangal and Stephen R Priebe, both of whom have contributed to various projects and innovations in the pharmaceutical sector.

Conclusion

Nipun Davar's work exemplifies the spirit of innovation in the field of pharmaceuticals. His patents not only demonstrate technical expertise but also reflect a commitment to improving patient care through advanced medication delivery systems. As he continues to push the boundaries of scientific research, Davar remains an influential figure in the world of drug development and formulation.